Twist Bioscience (TWST)
(Delayed Data from NSDQ)
$33.68 USD
+0.11 (0.33%)
Updated Aug 1, 2025 04:00 PM ET
After-Market: $33.71 +0.03 (0.09%) 7:58 PM ET
3-Hold of 5 3
D Value B Growth B Momentum C VGM
Fundamental Charts
About PEG Ratio (TTM)
The company's trailing twelve month (TTM) PEG ratio is the P/E ratio divided by its long-term growth rate consensus. This ratio essentially compares the P/E to its growth rate, thus, for many, telling a more complete story than just the P/E ratio alone. Conventional wisdom says that a PEG ratio of 1 or less is considered good (at par or undervalued to its growth rate). A value greater than 1, in general, is not as good (overvalued to its growth rate). For example, a company with a P/E ratio of 25 and a growth rate of 20% would have a PEG ratio of 1.25 (25 / 20 = 1.25). A company with a P/E ratio of 40 and a growth rate of 50% would have a PEG ratio of 0.80 (40 / 50 = 0.80). Traditionally, investors would look at the stock with the lower P/E and deem it a bargain. But when compared to its growth rate, it doesn't have the earnings growth to justify its P/E. In this example, the one with the P/E of 40 is the better bargain because it is selling at a discount to its growth rate. So the PEG ratio tells you what you're paying for each unit of earnings growth.
TWST 33.68 +0.11(0.33%)
Will TWST be a Portfolio Killer in August?
Zacks Investment Research is releasing its prediction for TWST based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for TWST
Twist Bioscience (TWST) Reports Q2 Loss, Tops Revenue Estimates
The Zacks Analyst Blog Highlights Illumina, BEAM, Twist Bioscience, Wave Life Sciences and CRISPR Therapeutics
TWST: What are Zacks experts saying now?
Zacks Private Portfolio Services
Promising Genomics & Synthetic Biology Stocks to Consider in 2025
Twist Bioscience (TWST) Moves 6.6% Higher: Will This Strength Last?
Avantor Stock Declines Despite Q4 Earnings Beat, Margins Expand
Other News for TWST
Preview: Twist Bioscience's Earnings
Twist Bioscience Q3 2025 Earnings Preview
Twist Bioscience Expands In Vivo Antibody Discovery Services with Launch of Humanized ...
Twist Bioscience Corp (TWST) Announces Equity Awards to New Employees | TWST stock news
Twist Bioscience Corporation Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) | ...